AFP
EXAS

Ausdal Financial Partners’s Exact Sciences EXAS Stock Holding History

Ausdal Financial Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,146
Closed -$218K – 1007
2025
Q4 		$218K Sell
2,146
-88,842
-98% -$7.13M 0.01% 868
2025
Q3 		$4.98M Buy
+90,988
New +$4.55M 0.24% 100
2016
Q1 		– Sell
-1,400
Closed -$13K – 476
2015
Q4 		$13K Buy
+1,400
New +$13K 0.01% 837

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Ausdal Financial Partners's EXAS Position: Q1 2026 in Review

Ausdal Financial Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,146 shares — an estimated $218K sold.

Ausdal Financial Partners first reported a position in EXAS in Q4 2015 and held it in 3 quarters. The position peaked at $4.98M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Ausdal Financial Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Ausdal Financial Partners sold 2,146 Exact Sciences shares in Q1 2026, an estimated $218K.
  • Ausdal Financial Partners first reported a position in Exact Sciences in Q4 2015 and held it in 3 quarters.
  • Ausdal Financial Partners's Exact Sciences position peaked at $4.98M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.